Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haluk A Savas

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Neuropsychobiology|October 16, 2002
Hippocampal volume in schizophrenia and its relationship with risperidone treatment: a stereological studyHaluk A Savas, Bunyami Unal, Hulya Erbagci, et al.
Neuropsychobiology|March 25, 2006
Atypical antipsychotic usage-related higher serum leptin levels and disabled lipid profiles in euthymic bipolar patientsH Serdar Gergerlioglu, Haluk A Savas, Ahmet Celik, et al.
Human Psychopharmacology|December 6, 2005
Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatmentHasan Herken, Omer Akyol, H Ramazan Yilmaz, et al.
Journal of Affective Disorders|September 15, 2006
Atypical antipsychotics related metabolic syndrome in bipolar patientsMehmet Yumru, Haluk A Savas, Erhan Kurt, et al.
Acta Neuropsychiatrica|May 27, 2014
Are oxidative stress markers useful to distinguish schizoaffective disorder from schizophrenia and bipolar disorder?Feridun Bulbul, Osman Virit, Gokay Alpak, et al.
Psychiatry Research|July 28, 2015
Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patientsU Sertan Copoglu, Osman Virit, M Hanifi Kokacya, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Neuropsychobiology|October 16, 2002
Hippocampal volume in schizophrenia and its relationship with risperidone treatment: a stereological studyHaluk A Savas, Bunyami Unal, Hulya Erbagci, et al.
Neuropsychobiology|March 25, 2006
Atypical antipsychotic usage-related higher serum leptin levels and disabled lipid profiles in euthymic bipolar patientsH Serdar Gergerlioglu, Haluk A Savas, Ahmet Celik, et al.
Human Psychopharmacology|December 6, 2005
Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatmentHasan Herken, Omer Akyol, H Ramazan Yilmaz, et al.
Journal of Affective Disorders|September 15, 2006
Atypical antipsychotics related metabolic syndrome in bipolar patientsMehmet Yumru, Haluk A Savas, Erhan Kurt, et al.
Acta Neuropsychiatrica|May 27, 2014
Are oxidative stress markers useful to distinguish schizoaffective disorder from schizophrenia and bipolar disorder?Feridun Bulbul, Osman Virit, Gokay Alpak, et al.
Psychiatry Research|July 28, 2015
Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patientsU Sertan Copoglu, Osman Virit, M Hanifi Kokacya, et al.
Pageof 3